Roche is narrowing its pipeline to 11 disease areas and continuing to invest in a targeted way, said Teresa Graham, chief ...

Severin Schwan criticized the subsidies that the U.S. and European governments are using to boost their manufacturing ...

Tolerability issues for CT-388 and CT-996 may impact Roche Holdings AG, but strong pipeline prospects remain. Discover why ...

Roche narrows pipeline to focus more on weight-loss franchise, following setbacks in Alzheimer's and lung cancer ...

New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a ...

Maybe you should dial back your training for better performance.

The TAGS technology has PCR testing capabilities on high-throughput systems such as the cobas 5800, 6800, and 8800 models.

Roche is rolling out what it describes as a new type of infectious disease diagnostic in Europe, with a single test capable ...

The TAGS technology – or Temperature-Activated Generation of Signal to give it its full name – allows up to 15 diagnostic ...

Swiss drug major Roche Group (RHHBY) announced Tuesday the launch of the cobas Respiratory flex test, the first to use Roche's novel ...

Basel: Roche announced today the launch of the cobas Respiratory flex test, the first to use Roche's novel and proprietary ...

Roche announced that the World Health Organization (WHO) has included dual-stain cytology testing in its cervical cancer prevention guideline. The Roche CINtec PLUS Cytology test is the only ...